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ABSTRACT 
 
Halogenated ligands have been widely developed as potent, and frequently selective, 
inhibitors of protein kinases (PK). Herein, all structures of protein kinases complexed with a 
halogenated ligand, identified in the PDB, were analyzed in the context of eventual contribution 
of halogen bonding to protein-ligand interactions. Global inspection shows that two carbonyl 
groups of residues located in the hinge region are the most abundant halogen bond acceptors. In 
contrast to solution data, well-defined water molecules, located at sites conserved across most 
PK structures, are also involved in halogen bonding. Analysis of cumulative distributions of 
halogen-acceptor distances shows that structures displaying short contacts involving a halogen 
atom are overpopulated, contributing together to clearly defined maxima of 2.82, 2.91 and 2.94 
Å for chlorine, bromine and iodine, respectively. The angular preference of a halogen bond 
favors ideal topology (180°, 120°) for iodine. For bromine the distribution is much more 
dispersed, and no such preference was found for chlorine.  
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INTRODUCTION 
Specific interactions between the halogen atoms (Cl, Br, I) of halogenated ligands and 
the electron pairs of oxygen/nitrogen/sulfur have been identified in many crystal structures of 
supramolecular ensembles [1-3] as well as in complexes between biomolecules and halogenated 
ligands [4-8]. In both cases this is based in part on the observation that the distance between a 
halogen atom and its electron-donating partner is significantly lower than the sum of their vdW 
radii (Figure 1). Fluorine, because of its high electronegativity, is a very poor halogen bond 
acceptor, but is a good acceptor from standard hydrogen bond donors [9]. 
Figure 1 
 Bearing in mind that numerous natural drugs, and an increasing number of synthetic 
drug candidates, are halogenated, understanding the nature and thermodynamics of halogen 
bonding should contribute to rational drug design. Halogenated compounds comprise 50% of 
current screening libraries [10], and almost 20% of low-mass protein ligands listed in the PDB 
are halogenated. Current widespread interest in elucidating the role of halogenated ligands in 
biological systems has been widely reviewed, amongst others, by Voth & Ho [7] and Parisini et 
al. [5], demonstrating that halogen bonding interactions are responsible for ligand recognition in 
many protein structures deposited in the PDB. Statistical analysis showed that such halogen 
bonds exhibit a geometry similar to that of hydrogen bonds [4], including a directional 
preference. However, despite the clear evidence of short halogen-bonding contacts in many 
protein-ligand structures, their energetic contribution is still under active debate [2, 6, 11-19]. 
Estimated contributions of halogen bonding to intra- and intermolecular interactions in aqueous 
medium vary from 0.2 [2] up to 5-8 kcal/mol [11]. The apparently largest values for X-bond 
contributions in solution were estimated, with the aid of IR spectroscopy, for CF3-X…N(CH3)3 
in liquid noble gases, as 2.1, 4.4 and 6.8 kcal/mol for X-bonds involving Cl, Br and I, 
respectively [13]. However, the fundamental problem concerning the relation between 
hydrophobic and electrostatic interactions, and the enthalpy of hydrogen vs. halogen bond 
formation, remains to be resolved. In most  experimental studies, in which the free energy of 
interaction of a ligand is usually compared to that of its halogenated counterpart, direct halogen 
bonding is assumed to be a major factor contributing to the observed differences in binding. 
Other interactions (e.g. hydrogen bonding, electrostatic interactions, and hydrophobic 
contribution) are frequently neglected.  
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One of the first reported inhibitors of the ubiquitous protein kinase CK2 [20], relatively 
selective when tested against a panel of more than 60 other kinases [21, 22], is 4,5,6,7-
tetrabromobenzo-1H-triazole (TBBt, see Figure 2). Other structurally closely related 
brominated analogues, TBBz (4,5,6,7-tetrabromo-1H-imidazole) [23], K59 (4,5,6,7-tetrabromo-
1H-indazole) and K6X (3,4,5,6,7-pentabromo-1H-indazole) [24] have been synthesized, and 
displayed even higher activity against CK2α [22, 24, 25]. Although TBBt, TBBz and K59 have 
very similar structures (see Figure 2), differing only by replacement of a single nitrogen in the 
triazole ring of TBBt by a C(2) or C(3) carbon in TBBz and K59, respectively, they differ 
significantly in physico-chemical properties, especially their pKa values (4.95, 8.05 and 10.6 
for TBBt, TBBz and K59, respectively). Furthermore, all three are sparingly soluble in neutral 
aqueous medium.  
Figure 2 
The foregoing differences in the crystal structures clearly indicate that binding of a 
halogenated ligand is driven by a balance of electrostatic, hydrophobic, hydrogen-bonding and 
halogen-bonding interactions, with the electrostatic component being predominant. This is 
supported by analysis of the structure-activity relations for a series of 4,6,7-
tribromobenzotriazole derivatives [26], in which the Br at C(5) of TBBt is replaced by various 
groups differing in their physicochemical properties, and for another series of nine 
bromobenzo-1H-triazoles representing all possible patterns of halogenation of the benzene ring 
[27]. Overall, the hydrophobicity of the monoanionic form of the ligand appeared to be the 
principal factor governing its inhibitory activity against CK2α [26, 28]. Furthermore, the 
moderate inhibitory activity exhibited by 4,5,6,7-tetramethylbenzotriazole [20], which, in 
contrast to TBBt, is in the neutral form at physiological pH [29], again points to a balance of 
electrostatic and hydrophobic interactions as important factors contributing to CK2α inhibition. 
Herein we present a detailed analysis of the geometry and topology of halogen bonds 
identified in all complexes of protein kinases with halogenated ligands are accessible in the 
Protein Data Bank. A statistical approach was applied to estimate, independently for Cl, Br and 
I as halogen bond donors, the free energy of halogen bond formation in protein-ligand systems, 
with some emphasis on protein kinase CK2.  
 
Material and methods 
Structural data 
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The PDB [30] was searched to identify all entries of protein kinases (enzyme 
classifications (EC) 2.7.10: tyrosine kinase; 2.7.11: serine/threonine kinase; 2.7.12: dual-
specificity kinase; 2.7.13: histidine kinase). Those containing ligands with at least one X-carbon 
bond (X = Cl, Br, I) were then analyzed. 
 
Strctural analysis 
 Analyses were performed with the aid of the Yasara Model package [31]. For each 
halogen bond donor (X), potential acceptors (Acc) were identified in a sphere of 4 Å radius. All 
protein oxygen atoms (i.e. backbone carbonyls, side-chain carbonyls of Asn and Gln, carboxyls 
of Asp and Glu, and hydroxyls of Ser and Thr), nitrogen atoms (backbone, and those of Arg, 
His and Lys), and side-chain sulphurs of Met and Cys, were assumed to be potential halogen 
bond acceptors. Following the concept of halogen bonding to π-electron systems [32], the 
centers of the aromatic rings of His, Phe, Tyr and Trp were also analyzed. Water molecules 
were also taken into account as potential halogen bond acceptors, albeit both experimental and 
theoretical data suggest that a water molecule is not an efficient halogen-bond acceptor. 
Binding of halide anions (Cl
-
, Br
-
 and I
-
), for which electrostatic interactions predominate, was 
excluded from the analysis.  
Structures of all protein kinases were aligned, using the modified MUSTANG algorithm 
[33] implemented in Yasara Structure. Multiple protein molecules in the crystal cell, as well as 
objects displaying partially occupied forms (i.e. side-chain rotamers or ligand locations) were 
analyzed separately. 
 
Statistical analysis 
Calculated cumulative distributions were based on all identified X…Acc distances. The 
superposition of one, two or three cumulative distribution functions (CDF) of the normal 
distribution, each with a mean μi and a standard deviation σi, was fitted to experimental data 
with the aid of the Marquardt algorithm [34] implemented in the GnuPlot program [35] 
according to the formula.  
 
i
iiderfdCDF ])/2/)[(1(5.0)(
2
 
The CDF analysis was restricted to X…Acc distances (d) smaller than the sum of the 
vdW radii of the X and Acc atoms (3.3, 3.4 and 3.5 Å for X = Cl, Br and I, respectively). 
  
RESULTS 
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PDB screening. 
A total of 334 entries were identified, among them 249, 73 and 33 with chlorinated, 
brominated and iodinated ligands, respectively. These entries were analyzed in terms of short 
contacts (4 Å threshold) between a halogen atom and a potential halogen bond acceptor (Acc: 
oxygen, nitrogen, sulfur and the center of the π-electron system of His, Phe, Tyr and Trp). 
In 69 structures no contacts were observed. In the remaining ones, 1131 short X…Acc 
contacts were identified (see Supplementary Table S1 for the list of all protein kinases 
identified). This includes 816 C-Cl…Acc, 260 C-Br…Acc and 55 C-I…Acc interactions. For 
each the X…Acc distance, and C-X…Acc and X…Acc-C angles (the latter with exception of a 
water molecule and a π-electron system), were determined to define the spatial preferences for 
formation of a halogen bond. Since the vdW radii of Cl, Br and I differ noticeably (1.75, 1.85 
and 1.98 Å, respectively), the three sets of contacts were analyzed separately. Sample sizes 
(816, 260 and 55) precluded a standard approach of  direct analysis of a probability distribution 
with reasonable bins’ size [4]. Hence an alternative approach, involving analysis of a 
cumulative distribution, was applied.  
 
Initial data verification 
All structures displaying abnormally short X…Acc distances were carefully inspected to 
trace unreported dehalogenation or other ambiguities. Thus, extremely short contacts between a 
halogen atom and a water molecule were identified in 3KXN (2.22 Å distance of 
I17
K8X…HOH480), in 3PVG (2.59 Å for Br19K68…HOH439), in 3AD5 (2.16 Å for 
Cl49
5PB…HOH154), in 2R3F (2.53 Å for Cl25SC8…HOH1205) and in 3LCD (2.66 Å for 
Cl17
BDY…HOH14). All of these were considered too short, and removed from further analysis. 
 
Analysis of X…Acc distance distribution 
Cumulative distributions for X…Acc distances, obtained independently for three data 
sets (Cl…Acc, Br…Acc and I…Acc), are presented in Figure 3.  
Figure 3 
The visible shoulders (see gray ellipses located close to 3Å), observed for all cumulative 
distributions, indicate that short contacts are overrepresented. This is most evident for the 
cumulative distribution of Br…Acc distances, in which the deviations in the short-distance 
region (i.e. below 3Å) explicitly define a remaining contribution from halogen bonding. 
Consequently, following the concept of halogen bonding, the CDF of two Gaussian 
distributions was fitted to the data (see dotted lines in Figure 3 A-C). At this stage, the CDF 
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function of superposition of two Gaussian distributions was found to reconstruct satisfactorily 
the cumulative distributions for X…Acc distances shorter than 3.30 and 3.40 A for Cl and Br, 
respectively. These two values agree with the sums of oxygen and halogen vdW radii, 3.27 and 
3.37 Å for Cl…O and Br…O, respectively. For longer distances, the distance distribution 
depends rather on the spatial preference of binding sites than on the energetics of direct 
interaction between a halogen atom and a potential acceptor. The short-distance distributions 
fitted for Cl…Acc (μ = 2.82 Å, σ = 0.08 Å, contribution 2%) and for Br…Acc (μ = 2.91 Å, σ = 
0.02 Å, 3%) are rough estimates of a contribution of halogen bonding in protein-ligand systems.  
As regards I…Acc distances, the small sample size (54 identified contacts, 44 shorter 
than a vdW cutoff of 3.5 Å) makes even a CDF barely qualitative. However, the fit of the CDF 
function corresponding to superposition of two normal distributions displays visible deviations 
below 3 Å. These deviations can be compensated for by a contribution from the third Gaussian 
distribution centered close to 3 Å (see dotted line in Figure 3C). The explicit X…Acc 
distributions can be directly calculated as formal derivatives of the fitted CDF. Inspection of 
Figure 3D-F shows that the estimated distance distributions perfectly reconstruct, up to vdW 
thresholds (3.3, 3.4 and 3.6 Å), histograms obtained with 0.1 Å bins (gray bars denote distances 
shorter than assumed thresholds). This again confirms that the proposed method of analysis of a 
cumulative distribution is at least as informative as the commonly used direct analysis of 
distance distribution 
In all cases the location of a short-distance local maximum follows the order of the vdW 
radii of halogen atoms (μ = 2.82, 2.91 and 2.94 Å for Cl, Br and I). The reverse trend observed 
in distribution widths (σ = 0.08, 0.02 and 0.01 Å, respectively) confirms that the chlorine atom 
is the weakest halogen bond donor.  
The estimated distributions of X…Acc distances can be converted to a thermodynamic 
semi-empirical potential of mean force (PMF), which can then be further used to verify the 
general force field parameterizations for halogen bonding [36-39]. These potentials, when 
determined separately for Cl…Acc, Br…Acc and I…Acc, show that the maximal stabilization 
of an X…Acc halogen bond is in the range of 0.5 kcal/mol for Cl to 1.5 kcal/mol for I. These 
values are approximately ten-fold lower that those reported by Voth et al [6], but agree with ab 
initio derived results for various X…Acc systems [40].  
 
Preferred geometry of a halogen bond.  
A total of 72 potential halogen bonds, unequivocally identified in 51 PDB structures of 
protein kinases, were inspected for a possible angular preference of halogen bonding (Figure 4).  
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Figure 4 
In principle, an almost linear conformation of the C-X…Acc fragment is strongly favored 
(i.e. θX ≈ 180°), but two distinguishable maxima (visible as shoulders in the cumulative 
distribution) are also evident (see Figure 5A). One of them, centered close to θX ≈ 123°, is 
characteristic for interaction of a halogen atom with a well-defined molecule. Thus, an isolated 
water molecule seems to be a strong halogen bond acceptor in numerous crystal structures of 
protein – ligand complexes, as represented by two ligand orientations in the complex of K37 
with CK2α, for which a water molecule competes with a carbonyl oxygen for a bromine donor 
(see Supplementary Figure S1). The third minimum, located at θX ≈ 160°, also noted by 
Auffinger et al. [4], is an alternative to a linear halogen bond. 
 More detailed analysis shows that the angular preference strongly depends on the type 
of halogen atom. Thus, the linear form of the C-X…Acc configuration exists for almost 60% of 
short contacts involving Iodine, but only approximately 30% for Bromine, and no preference 
for a linear X-bond is observed for Chlorine. This is additional evidence that Iodine is the 
strongest halogen bond donor, and Chlorine the weakest. 
The majority of X…Acc-C angles (θAcc) agrees with the expected location of a maximal 
electron density on a carbonyl. In three plots, clusters located at X…Acc-C (θAcc) = 125º and C-
X…Acc (θX) = 175º represent those with ideal X-bond geometry. It is clearly visible that the 
strongest preference for optimal geometry of a halogen bond is that for Iodine (Figure 4D). The 
X-bond structures are more dispersed for Bromine (Figure 4C) and much more so for Chlorine 
(Figure 4B). Note that for a water molecule, θAcc is undefined. 
 
Preferred topology of halogen bond network in the ATP binding site of protein kinases. 
The largest number of short X…Acc contacts, with at least 3 halogen atoms engaged in 
X-bonds, are visible for TBBt complexed with CDK2 (PDB ID:1P5E [41]) and for K37 (PDB 
ID: 1ZOG [42]), TBBz (PDB ID: 2OXY [23]) and K6X (PDB ID: 3KXG [24]) complexes with 
CK2α (see Supplementary Figure S1). In all these structures, and frequently in others, the 
backbone carbonyl oxygens of residues located in the hinge region (i.e. Glu114 and Val 116 in 
CK2α, and Glu81 and Leu83 in CDK2), are the most favored acceptors (see Supplementary 
Figure S2 for all complexes with identified halogen bonding to the hinge region). Two 
additional halogen bonds may be created with proximal water molecules, one of which is well 
defined at locations conserved among crystal structures of protein kinases [23]. However, one 
of the water molecules can be replaced by the backbone carbonyl oxygen of CDK2 Ile10 
(Val45 in CK2α), which precedes the phosphate anchor loop (p-loop, residues 46GRGKYS51 in 
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CK2α), and the other by a side-chain carboxyl of Asp175 (Asp145 in CDK2), which is located 
in the Mg
2+
-binding loop (
175
DWG
177
 motif in CK2α).  
In two of these crystal structures (PDB IDs: 1P5E, 2OXY), the patterns of halogen 
bonds remain identical for both protein molecules located in the crystal asymmetric unit. In two 
other structures (PDB IDs: 1ZOG, 3XKN) two alternative, partially occupied, locations of the 
ligand in the binding pocket are visible. However, in all these structures a pattern of close 
contacts of ligand halogen atoms with backbone carbonyls of residues located in the N-terminal 
part of the hinge region is preserved for three different orientations of the ligands. In the next 
two structures (PDB IDs: 3KXG, 1J91), the proteins display partial occupancy of two 
conformers, in one of which a halogen bond with the ligand is observed.  
It should be emphasized that, despite differences in orientation of the ligand in the 
binding pocket, it is the pattern of halogen bonds that is preserved rather than the location of a 
ligand (Figure 5).  
Figure 5 (STEREO). 
Of 51 identified structures, 23 represent the most populated pattern of interactions (Figure 5, 
see also Supplementary Figure S2 and Supplementary Table S1), in which halogenated ligands 
make direct halogen bond contacts with the side-chain carbonyls of the N-terminal part of the 
kinase hinge/αD region. In most of these structures, the carbonyl groups of residues located in 
the N-terminal part of the hinge region are halogen bond acceptors (PDB IDs: 1P5E and 3MY5 
of CDK2; 3MY1 of CKD9; 1ZOE, 1ZOG, 1ZOH, 2OXD, 2OXX, 2OXY, 3KXG, 3KXM, 
3KXN, 3PVG and 3OFM of CK2α; and 2VAG of CLK1). Halogen bonds may also be formed 
with other residues located in the hinge region (PDB IDs: 1CKP and 1H1R of CDK2; 1PMN 
and 1PMQ of JNK3; and 2ZOQ of ERK1), or even with a proximal water molecule (PDB ID: 
1WCC of CDK2).  
An alternative halogen bonding mode occurs to the p-loop region (Arg43-Phe54 in 
CK2α) in 1J91, 1ZLT, 2GU8, 2UW8, 2X6D 3NGA 3SDO, frequently accompanying hydrogen 
bonding between a ligand and backbone carbonyls of residues located in the hinge region (see 
Supplementary Figure S3). Other potential acceptors for halogen bonds are residues located in 
the DWG motif of the Mg
2+
-binding loop (Asp175-Gly177 in CK2α). Thus, the side-chain 
carboxyl of Asp (PDB IDs: 1ZOH, 3KXG, 1Q4L, 1FVT, 1UV5, 3ZZ2), a backbone carbonyl of 
Gly (PDB IDs: 2XP2, 2YFX), a side-chain hydroxyl of the Ser preceding the DWG motif (PDB 
IDs: 2Y6O, 3PJ1), or the π-electron system of Phe (PDB ID: 3SOA; in which F corresponds to 
W in the DWG motif of CK2α), also participate in halogen bonding (see Supplementary Figure 
S4). 
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DISCUSSION 
It should be noted that an unexpectedly large number of extremely short contacts (< 3Å) 
between a water molecule and a halogen atom were identified (PDB IDs: 1P5E, 1ZOE, 1ZOG, 
2OXD, 2OXY, 3PVG, 1WCC, 2R3F, 2R3P, 2C47, 1S9J). This substantially disagrees with 
solution data [2, 43], and also with results of QM calculations [40], which predict that a water 
molecule is not a halogen bond acceptor. It could thus be concluded that the weak accepting 
properties of a water molecule result from the large entropic contribution upon formation of an 
eventual halogen bond. This unfavored term is diminished for a water molecule tightly bound to 
the protein, and thus a halogen bond could be formed in a ligand-water-protein ternary system. 
In this context, halogen bonding to an isolated water molecule should be considered in ligand-
protein interactions as an alternative to water-bridged hydrogen bonding.  
In two structures, 1P5E [41] and 2OXY [23], ligand locations in two complexes made 
with different protein molecules in the asymmetric unit remain identical. By contrast, two 
alternative locations of K37 complexed with CK2α differ in orientation by 60°, but the pattern 
of two halogen bonds to Glu114 and Val116 is preserved (see Supplementary Figure S1. In the 
complex of K6X with CK2α, two alternative rotamers of the Asp173 side-chain are partially 
populated, but only one makes a halogen bond with the ligand. Such variations in ligand 
orientation are observed for numerous ligands, clearly denoting only a minor contribution of 
halogen bonding to stabilization of the ligand-protein complex, additionally supported by 
differences in the pattern of halogen bonding within partially populated conformations, or in 
different molecules from the same crystal unit.  
Inspection of crystal structures of TBBt, TBBz and K64 complexed with CK2α [28] 
reveals significant differences in their location in the ATP binding site, as well as in the 
topology of the intermolecular halogen bonds. Thus, location of TBBz is constrained by non-
polar contacts, and two halogen bonds between the backbone carbonyls of E114 and V116 with 
the vicinal Br5 and Br6 atoms (3.16 and 2,95 Å, respectively), whereas K64, which is rotated in 
the complex by ~60º, retains a halogen bond with V116 (2.85 Å) and a long-range halogen-
bond-like contact with E114 (>3.5 Å), but also forms an additional halogen bond with the D175 
side-chain in one of its partially occupied conformations (3.09Å). In striking contrast, location 
of TBBt is stabilized, apart from non-polar contacts, mainly by electrostatic interactions 
between the triazole ring and the side-chains of K68 and D175, and an orthogonal halogen 
bond, see [6] for a definition, between the Nε of R47 and a peripheral Br4/Br7 of TBBt (2.99 
Å), inadvertently overlooked by the authors [44]. All three ligands also make numerous 
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contacts with well-defined surrounding water molecules, the oxygen atoms of some of which 
are closer than the nominal limit for an O…Br halogen bond (3.3 Å) (see Figure 7) 
There are also some ligands (e.g. CX-4945, the most promising CK2α inhibitor, now in 
clinical trials) which are bound in a halogen bond-promoting mode, but distances between the 
halogen atom and proximal halogen bond acceptors are too long. Structural analysis 
demonstrates that in the complex of CX-4945 with CK2α, the small hydrophobic cavity is large 
enough to host not only chlorine [45], but also the larger bromine, or even iodine, attached to 
the meta-position of the benzene ring of the parent CX-4945 inhibitor. Consequently, 
replacement of Cl by either Br or I increases the hydrophobic contribution to the free energy of 
binding, which may additionally be enforced by creation of a halogen bond with the carbonyl of 
Gly46. A preliminary in silico study, with the aid of a docking procedure, showed that 
replacement of Cl by Br increases the free energy of binding by 0.25 kcal/mol, and by 0.35 
kcal/mol when Cl is replaced by I. 
It should also be noted that halogenation of a ligand may change its pKa, and/or even 
the tautomeric/protomeric equilibrium experienced by proximal dissociable groups. This may 
result in modulation of hydrogen bonding interactions, which accompanies eventual halogen 
bonding. Thus, the reported activity of a series of halogenated PDE-5 inhibitors correlates with 
the calculated energies of halogen bonding with a  tyrosine hydroxyl group [46], albeit the 
authors neglected, the significant contribution from two hydrogen bonds created between the 
ligand and a Gln817 side-chain, for which the estimated energies, based on crystal structures 
(PDB IDs: 3SHY, 3SHZ and 3SIE, are 25.3, 32.0 and 37.9 kJ/mol for fluoro-, chloro- and 
bromo- derivatives, respectively, visibly correlating with the reported IC50 values (R
2
=0.98)  
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Figures 
 
Figure 1. Schematic representation of a halogen bond  
 
Figure 2. Effective multihalogenated inhibitors of CK2α. 
 
Figure 3. CDF analysis based on the assumption that the observed X…Acc distribution 
(represented as cumulative distribution) of a normal distribution (A, B, C, solid lines) or a 
superposition of two or three normal distributions (A, B, C dotted lines). Gray ellipses denote 
the significant deviations from a normal distribution. In bottom row a comparison of CDF-
derived distributions with frequency histograms calculated with 0.1 Å bins. All X…Acc pairs 
separated by more than the sum of their vdW radii were excluded from the analysis. 
 
Figure 4. Cumulative distributions of C-X…Acc angles for 72 identified halogen bonds 
obtained separately for different halogen bond donors (A), and scatterplots for C-X…Acc vs. 
X…Acc-C angles demonstrating geometrical preferences for halogen bonds involving Cl (B), 
Br (C) and I (D), respectively. Gray ellipses denote the most favored geometry of a C-X…O=C 
halogen bond. 
 
Figure 5. Stereo representation of halogen bonds identified in the ATP-binding pocket of 
protein kinases. Gray neons represent individual halogen bonds, and green ones trace the 
protein backbone. Water molecule (Wat), which location is conserved among the crystal 
structures of various protein kinases, is engaged in halogen bonding similarly to backbone 
carbonyls from the hinge region. 
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